City

Bethesda (1)

Bloemfontein (1)

Boston (1)

Pittsburgh (1)

San Juan (1)

Overall Status

Completed (3)

Phase

phase 1 (3)

Sponsor

Antiva Biosciences (1)

CONRAD (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

National Institute of Mental Health (NIMH) (1)

National Institutes of Health (NIH) (1)

Intervention

hec placebo gel (1)

tenofovir 1% gel (1)

topical abi-1968 (1)

vrc-hivadv014-00-vp (1)

vrc-hivdna016-00-vp (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (3)

hiv negative

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HSIL of Cervix, HSIL, High Grade Squamous Intraepithelial Lesions, High-Grade Cervical Intraepithelial Neoplasia Trial in

Completed

HSIL of Cervix
+8 more

Topical ABI-1968

Bloemfontein, Free State Province, South Africa

Research Center

Jan 11, 2021

HIV Negative, Adaptive Immunity, Innate Immunity Trial run by the NIAID (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP)

Completed

HIV Negative
+2 more

VRC-HIVDNA016-00-VP
VRC-HIVADV014-00-VP

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Dec 13, 2019

High Risk MSM, HIV Negative, 18-30 Years of Age Trial in Boston, Pittsburgh, San Juan (HEC Placebo Gel, Tenofovir 1% Gel)

Completed

High Risk MSM
+2 more

HEC Placebo Gel
Tenofovir 1% Gel

Boston, Massachusetts
+2 more

May 27, 2015